Categories
Recent Articles
-
How Does Retatrutide Influence Cardiovascular Risk Factors?
39 days ago
Retatrutide improves cardiovascular health by significantly lowering blood pressure, reducing harmful lipids, and promoting weight...
-
TB-500 for Pulmonary Fibrosis: Shifting the Repair Paradigm
40 days ago
TB-500, a synthetic thymosin β-4 fragment, is gaining attention in pulmonary fibrosis research for its...
All product descriptions and articles provided on this website are intended strictly for informational and educational purposes. Our products are designed exclusively for in-vitro research (i.e., experiments conducted outside of a living organism, typically in glassware such as test tubes or petri dishes). These compounds are not approved by the FDA for use in humans or animals. They are not medications, nor are they intended to diagnose, treat, prevent, or cure any disease or medical condition. Any bodily administration-human or animal-is strictly prohibited by law. Our products are not for human consumption under any circumstances.
How Does Retatrutide Influence Cardiovascular R...
Retatrutide improves cardiovascular health by significantly lowering blood pressure, reducing harmful lipids, and promoting weight loss. Its triple receptor agonism targets multiple metabolic pathways, offering comprehensive risk reduction for heart disease. Ongoing clinical trials support its potential as a breakthrough therapy for obesity and cardiometabolic complications, advancing research and treatment options.
TB-500 for Pulmonary Fibrosis: Shifting the Rep...
TB-500, a synthetic thymosin β-4 fragment, is gaining attention in pulmonary fibrosis research for its regenerative and anti-inflammatory effects. Unlike current antifibrotics that only slow scarring, TB-500 may promote true lung repair by targeting fibroblast activity, angiogenesis, and epithelial healing. Preclinical studies show encouraging results, but human trials are essential to confirm its therapeutic potential.
